First Header Logo Second Header Logo

Connection

Yaron Barac to Indans

This is a "connection" page, showing publications Yaron Barac has written about Indans.
Connection Strength

0.580
  1. Barac YD, Bar-Am O, Liani E, Amit T, Frolov L, Ovcharenko E, Angel I, Youdim MB, Binah O. I1 imidazoline receptor: novel potential cytoprotective target of TVP1022, the S-enantiomer of rasagiline. PLoS One. 2012; 7(11):e47890.
    View in: PubMed
    Score: 0.380
  2. Malka A, Meerkin D, Barac YD, Malits E, Bachner-Hinenzon N, Carasso S, Ertracht O, Angel I, Shofti R, Youdim M, Abassi Z, Binah O. TVP1022: A Novel Cardioprotective Drug Attenuates Left Ventricular Remodeling After Ischemia/Reperfusion in Pigs. J Cardiovasc Pharmacol. 2015 Aug; 66(2):214-22.
    View in: PubMed
    Score: 0.115
  3. Abassi ZA, Barac YD, Kostin S, Roguin A, Ovcharenko E, Awad H, Blank A, Bar-Am O, Amit T, Schaper J, Youdim M, Binah O. TVP1022 attenuates cardiac remodeling and kidney dysfunction in experimental volume overload-induced congestive heart failure. Circ Heart Fail. 2011 Jul; 4(4):463-73.
    View in: PubMed
    Score: 0.086
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.